Choroid plexus implants rescue Alzheimer's disease-like pathologies by modulating amyloid-β degradation

Cellular and Molecular Life Sciences : CMLS
Marta BolosE Carro

Abstract

The choroid plexuses (CP) release numerous biologically active enzymes and neurotrophic factors, and contain a subpopulation of neural progenitor cells providing the capacity to proliferate and differentiate into other types of cells. These characteristics make CP epithelial cells (CPECs) excellent candidates for cell therapy aiming at restoring brain tissue in neurodegenerative illnesses, including Alzheimer's disease (AD). In the present study, using in vitro approaches, we demonstrated that CP were able to diminish amyloid-β (Aβ) levels in cell cultures, reducing Aβ-induced neurotoxicity. For in vivo studies, CPECs were transplanted into the brain of the APP/PS1 murine model of AD that exhibits advanced Aβ accumulation and memory impairment. Brain examination after cell implantation revealed a significant reduction in brain Aβ deposits, hyperphosphorylation of tau, and astrocytic reactivity. Remarkably, the transplantation of CPECs was accompanied by a total behavioral recovery in APP/PS1 mice, improving spatial and non-spatial memory. These findings reinforce the neuroprotective potential of CPECs and the use of cell therapies as useful tools in AD.

References

May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J BartekJ Taylor-Papadimitriou
Apr 6, 2001·The American Journal of Pathology·Y MatsuokaK Duff
May 26, 2001·Science·N IwataT C Saido
Aug 8, 2002·Journal of Drug Targeting·Jean-François Ghersi-Egea, Nathalie Strazielle
Sep 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Simona CapsoniAntonino Cattaneo
Nov 5, 2002·Nature Medicine·E CarroI Torres-Aleman
Jun 3, 2004·Annals of Neurology·Fabrizio TrincheseOttavio Arancio
Jul 31, 2004·Stroke; a Journal of Cerebral Circulation·Cesar V BorlonganDwaine F Emerich
Sep 24, 2004·Advanced Drug Delivery Reviews·Elizabeth C M de Lange
Feb 18, 2005·Journal of Neurochemistry·Jiraganya BhongsatiernTetsuya Terasaki
Apr 27, 2005·Nature Medicine·Mark H TuszynskiJames Conner
Jun 25, 2005·Current Drug Targets. CNS and Neurological Disorders·Annemieke J M RozemullerPiet Eikelenboom
Jun 17, 2006·Neurobiology of Disease·Dwaine F EmerichJeffrey H Kordower
Jan 23, 2009·Journal of Alzheimer's Disease : JAD·Han-Chang Huang, Zhao-Feng Jiang
Jun 26, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Donna M WilcockCarol A Colton
Jan 15, 2010·The Journal of Biological Chemistry·G William RebeckCharbel E-H Moussa
Jun 4, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pierre GarciaThierry Pillot
Jul 20, 2010·Molecular and Cellular Neurosciences·Ximena Alvira-BoteroEva Carro
Aug 26, 2010·Current Aging Science·Ximena Alvira-Botero, Eva M Carro
Dec 15, 2010·Science·Kwasi G MawuenyegaRandall J Bateman
Sep 10, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Andrew K WiseRobert K Shepherd
Mar 2, 2012·Dementia and Geriatric Cognitive Disorders·Maria Eriksdotter-JönhagenLars Wahlberg
Mar 5, 2013·Cellular and Molecular Life Sciences : CMLS·Marta BolosEva Carro

❮ Previous
Next ❯

Citations

Dec 3, 2014·Frontiers in Neuroscience·Brent Roy Bill, Vladimir Korzh
May 24, 2016·Neural Regeneration Research·Sriram BalusuRoosmarijn E Vandenbroucke
May 18, 2016·Neuroscience Letters·Kelly C S RoballoCarlos E Ambrósio
Dec 23, 2016·Annals of the American Thoracic Society·Roosmarijn E. Vandenbroucke
May 18, 2020·Journal of Neuropathology and Experimental Neurology·Conrad E JohansonEsteban M Rodríguez
Mar 30, 2017·Fluids and Barriers of the CNS·Jianming XiangRichard F Keep
May 8, 2020·Fluids and Barriers of the CNS·Peter SolárMarek Joukal
Feb 29, 2020·Neurobiology of Aging·Ehsan TadayonUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Dec 24, 2018·Aging and Disease·Antonina LucaMaria Luca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.